---
title: "Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295022969.md"
description: "Corcept Therapeutics Chief Accounting & Technology Officer Joseph Douglas Lyon sold 1,540 common shares on August 3, 2026, at $114.16 per share, totaling $175,806.40. Following the transaction, Lyon retains beneficial ownership of 5,495 shares. The disclosure was filed via EDGAR on August 5, 2026."
datetime: "2026-08-05T22:11:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295022969.md)
  - [en](https://longbridge.com/en/news/295022969.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295022969.md)
generator: "portal-rs"
---

# Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40

-   Corcept Therapeutics Chief Accounting & Technology Officer Joseph Douglas Lyon sold 1,540 common shares on Aug. 3, 2026. \* Shares were sold at $114.16, leaving him with 5,495 shares beneficially owned. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-335605), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CORT.US](https://longbridge.com/en/quote/CORT.US.md)

## Related News & Research

- [Corcept Oncology President Roberto Wandenkolk Vieira disposes of USD 6.31 million in common shares](https://longbridge.com/en/news/297973214.md)
- [Corcept names Roberto Vieira as President, Oncology in initial beneficial ownership filing](https://longbridge.com/en/news/297971867.md)
- [Inter Parfums announces availability of 2026 half-year report](https://longbridge.com/en/news/298413126.md)
- [nLIGHT CFO Joseph John Corso disposes of 7,715 common shares worth $321,274.31](https://longbridge.com/en/news/298370085.md)
- [Biovica publishes Q1 2026/27 quarterly report release](https://longbridge.com/en/news/298482629.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**